ES2167375T3 - Derivados flavonoides y bioflavonoides, sus composiciones farmaceuticas, su actividad ansiolitica. - Google Patents

Derivados flavonoides y bioflavonoides, sus composiciones farmaceuticas, su actividad ansiolitica.

Info

Publication number
ES2167375T3
ES2167375T3 ES94924912T ES94924912T ES2167375T3 ES 2167375 T3 ES2167375 T3 ES 2167375T3 ES 94924912 T ES94924912 T ES 94924912T ES 94924912 T ES94924912 T ES 94924912T ES 2167375 T3 ES2167375 T3 ES 2167375T3
Authority
ES
Spain
Prior art keywords
sub
derivatives
ansiolitical
bioflavonoid
flavonoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924912T
Other languages
English (en)
Inventor
Bruce Kennedy Cassels
Federico Jose Dajas
Jorge Horacio Medina
Alejandro Constantino Paladini
Rodolfo Horacio Silveira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Application granted granted Critical
Publication of ES2167375T3 publication Critical patent/ES2167375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

SE HA ENCONTRADO QUE CIERTOS FLAVONOIDES, NOTABLEMENTE DERIVADOS DE LA FLAVONA, CRISINA Y APIGENINA JUNTO CON DIMEROS DE LOS MISMOS TALES COMO LA AMENTOFLAVONA, POSEEN PROPIEDADES ANSIOLITICAS (POR EJEMPLO PROPIEDADES REDUCTORAS DE LA ANSIEDAD) SIN EXHIBIR EFECTOS SEDANTES. LOS COMPUESTOS SON DEFINIDOS POR LA FORMULA GENERAL (I), EN LA QUE R1, R2, R3, R4, R5 Y R8 SE SELECCIONAN INDEPENDIENTEMENTE ENTRE H, OH, R, NO{SUB,2}, HALO, OR, NH{SUB,2}, NHR, NR{SUB,2}, COOR, COOH, CN O UN GRUPO DE AZUCAR; R6, Y R7 SON AMBAS H, O R6 Y R7 JUNTAS FORMAN UN ANILLO SIMPLE; R ES ALQUIL C{SUB,1-6} O ALQUENILO; TAMBIEN SE DESCRIBE LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA, NO TOXICA DE UN BIFLAVONOIDE QUE ES UN DIMERO DE UN COMPUESTO DE LA FORMULA GENERAL (I). TAMBIEN SE DESCRIBEN NUEVOS COMPUESTOS Y FORMULACIONES FARMACEUTICAS.
ES94924912T 1993-08-17 1994-08-17 Derivados flavonoides y bioflavonoides, sus composiciones farmaceuticas, su actividad ansiolitica. Expired - Lifetime ES2167375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939317071A GB9317071D0 (en) 1993-08-17 1993-08-17 Flavonoids

Publications (1)

Publication Number Publication Date
ES2167375T3 true ES2167375T3 (es) 2002-05-16

Family

ID=10740608

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924912T Expired - Lifetime ES2167375T3 (es) 1993-08-17 1994-08-17 Derivados flavonoides y bioflavonoides, sus composiciones farmaceuticas, su actividad ansiolitica.

Country Status (7)

Country Link
US (2) US5756538A (es)
EP (1) EP0714296B1 (es)
JP (1) JPH09501440A (es)
DE (1) DE69429003T2 (es)
ES (1) ES2167375T3 (es)
GB (1) GB9317071D0 (es)
WO (1) WO1995005169A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
EP1245230A3 (en) * 1995-06-23 2003-11-26 Advanced Life Sciences Inc. Amentoflavone as an antiviral agent
GB9521184D0 (en) * 1995-10-17 1995-12-20 Univ Strathclyde Flavonoids
GB9707013D0 (en) * 1997-04-07 1997-05-28 Univ Strathclyde Halo and/or nitro-substituted flavonoids
US7718694B2 (en) * 1997-10-16 2010-05-18 Children's Hospital & Research Center At Oakland Compositions and methods for therapy for diseases characterized by defective chloride transport
US5972995A (en) * 1997-10-16 1999-10-26 Children's Hospital Medical Center Of Northern California Compositions and methods for cystic fibrosis therapy
KR100395338B1 (ko) * 1999-07-09 2003-08-19 김박광 크리신 유도체 및 이들을 포함한 혈당강하제용 조성물
EP1218002A4 (en) 2000-01-24 2004-09-22 Jozef S Mruk USE OF FLAVON-8 ACETIC ACID IN VASCULAR AND CARDIOVASCULAR INTERVENTIONS AND ACUTE CORONARY SYNDROME
US7183314B1 (en) 2000-07-21 2007-02-27 Naturon Limited Compound for treatment of anxiety and methods of preparation and use thereof
US7034054B2 (en) * 2000-12-15 2006-04-25 Galileo Pharmaceuticals, Inc. Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
DE60232140D1 (de) * 2001-03-23 2009-06-10 Nutricia Nv Zusammensetzung zur prävention und/oder behandlung von verändertem knochenmetabolismus
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US20030165588A1 (en) 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
CA2703698C (en) 2002-04-30 2016-11-22 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
US6884783B2 (en) 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids
US8138165B2 (en) * 2002-10-22 2012-03-20 Jenken Biosciences, Inc. Chromones and chromone derivatives and uses thereof
CN1798568B (zh) 2003-04-04 2011-05-11 尤尼根制药公司 用于哺乳动物皮肤护理的双重环氧合酶(cox)以及脂氧合酶(lox)抑制剂的组合物
EP1660109A4 (en) * 2003-09-02 2009-04-08 Unigen Pharmaceuticals Inc FORMULATION OF A MIXTURE OF FREE B-RING FLAVONOIDS AND FLAVANES FOR USE IN THE PREVENTION AND TREATMENT OF COGNITIVE WEAKNESSING AND AGING MEMORY DISORDERS
KR100610562B1 (ko) * 2004-06-28 2006-08-08 재단법인서울대학교산학협력재단 플라보노이드 유도체를 포함하는 급성 또는 만성 퇴행성뇌질환의 예방 또는 치료용 조성물
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
CA2587406A1 (en) * 2004-11-16 2006-05-26 Limerick Neurosciences, Inc. Methods and compositions for treating pain
TWI454261B (zh) 2007-01-09 2014-10-01 Unigen Inc 作為治療劑之色酮類
CA2677892A1 (en) * 2007-02-14 2008-12-04 Mars, Incorporated Neurogenic compounds
US7722522B2 (en) * 2008-02-11 2010-05-25 Gregg Alan Klang Brace providing focused energy for medical therapy
BRPI0801239A2 (pt) * 2008-04-01 2009-11-17 Ache Lab Farmaceuticos Sa uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
US20100075926A1 (en) * 2008-07-23 2010-03-25 Li-Huei Tsai Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
EP2323649A4 (en) * 2008-07-25 2011-09-07 Univ Emory TREATMENT OF VARIOUS DISORDERS WITH 7,8-DIHYDROXY FLAVONE AND ITS DERIVATIVES
CA2801415A1 (en) 2010-06-09 2011-12-15 Emory University Trkb agonists and methods of use
RS58438B1 (sr) 2011-07-22 2019-04-30 Massachusetts Inst Technology Aktivatori klase i histonskih deacetilaza (hdacs) i njihova primena
WO2014018741A1 (en) 2012-07-27 2014-01-30 Emory University Heterocyclic flavone derivatives, compositions, and methods related thereto
JP6564030B2 (ja) * 2014-10-21 2019-08-21 ブダク, メフメトBudak, Mehmet パパベル ロエアス（Ｐａｐａｖｅｒ ｒｈｏｅａｓ）から得られる新規分子を含む組織及び細胞染料処方
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
CN108250172A (zh) * 2017-11-22 2018-07-06 中国科学院西北高原生物研究所 一种具有抗焦虑功效的化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903266A (en) * 1972-05-03 1975-09-02 Ralph C Robbins Compositions and methods for disaggregating blood cells
US4241069A (en) * 1979-09-04 1980-12-23 Miles Laboratories, Inc. 3-Methylene flavanones and 3-methylene chromanones
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds

Also Published As

Publication number Publication date
DE69429003T2 (de) 2002-07-11
EP0714296B1 (en) 2001-11-07
WO1995005169A1 (en) 1995-02-23
EP0714296A1 (en) 1996-06-05
US6004998A (en) 1999-12-21
DE69429003D1 (de) 2001-12-13
GB9317071D0 (en) 1993-09-29
US5756538A (en) 1998-05-26
JPH09501440A (ja) 1997-02-10

Similar Documents

Publication Publication Date Title
ES2167375T3 (es) Derivados flavonoides y bioflavonoides, sus composiciones farmaceuticas, su actividad ansiolitica.
MX9202166A (es) Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes.
YU149791A (sh) Mometason, furoat monohidrat i postupak za njegovo dobijanje
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9400206A (es) Derivados de vinil-azaindol, proceso para su preparacion y composiciones farmaceuticas que los contienen.
MX9306986A (es) Composiciones farmaceuticas a base de taxoides.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
EA199900242A1 (ru) Аралкил- и аралкилиден-гетероциклические лактамы и имиды
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ATE148610T1 (de) Antimikrobielle mittel sowie substituierte 2- cyclohexan-1-yl-amin-derivate und deren herstellung
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DK0630366T3 (da) Substituerede heterocycliske derivater, der er nyttige som blodpladeaggregeringsinhibitorer
NO923265D0 (no) Benzol(f)quinolinoner
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
SE8600658D0 (sv) Novel composition of matter
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.